Search

Your search keyword '"Kuroha M"' showing total 160 results

Search Constraints

Start Over You searched for: Author "Kuroha M" Remove constraint Author: "Kuroha M"
160 results on '"Kuroha M"'

Search Results

5. P822 Genetic analysis of ulcerative colitis in Japanese individuals using population-specific SNP array

9. Usefulness of a peripherally inserted central catheter for total parenteral nutrition in patients with inflammatory bowel disease

21. Effects of altered plasma α-1-acid glycoprotein levels on pharmacokinetics of some basic antibiotics in pigs: simulation analysis.

29. γ-ray Compton Profiles of Liquid Alkali Metals(Physics)

30. Transport properties of as-grown MgB2 films using micro-bridge

31. Transmission electron microscopy study of as-grown MgB2 films

32. Optimization of co-evaporation conditions of as-grown MgB2 thin films by molecular beam epitaxy

33. Usefulness of Mirogabalin in Central Neuropathic Pain After Stroke: Post Hoc Analysis of a Phase 3 Study by Stroke Type and Location.

34. Is initial unilateral revascularization acceptable in pediatric patients with bilateral moyamoya disease with mild contralateral hemodynamic disturbance?

35. Dickkopf 1 is expressed in normal fibroblasts during early stages of colorectal tumorigenesis.

36. Comparative Effectiveness of Tacrolimus and Infliximab in Hospitalized Patients With Ulcerative Colitis.

37. Usefulness and difficulties with the thiopurine pharmacogenomic NUDT15 genotyping test: Analysis of real-world data in Japan.

38. Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia.

40. Reduced antiviral seropositivity among patients with inflammatory bowel disease treated with immunosuppressive agents.

41. Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia.

42. Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor.

43. Response to COVID-19 vaccine is reduced in patients with inflammatory bowel disease, but improved with additional dose.

44. Long-term effectiveness of ustekinumab comparable to antitumor necrosis factor agents in patients with Crohn's disease.

45. Serum leucine-rich alpha-2 glycoprotein as a predictive factor of endoscopic remission in Crohn's disease.

46. Endoscopic radial incision and cutting for benign stenosis of the lower gastrointestinal tract: An investigation of novel endoscopic treatment in multicenter trial.

47. Effectiveness of colonic stent placement for obstructive colorectal cancers: An analysis of short-term results using a nationwide database in Japan.

48. Validity of Diagnostic Algorithms for Inflammatory Bowel Disease in Japanese Hospital Claims Data.

49. Discovery of EP300/CBP histone acetyltransferase inhibitors through scaffold hopping of 1,4-oxazepane ring.

50. Crohn's Disease and Early Exposure to Thiopurines are Independent Risk Factors for Mosaic Chromosomal Alterations in Patients with Inflammatory Bowel Diseases.

Catalog

Books, media, physical & digital resources